ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access

Muhammad Jamal Yawuz1 , Muhammad Qais Fadhil Ahmed1 and Sarmad Abdulrasool Mohammed2

1Clinical Pharmacy Department, College of Pharmacy, University of Baghdad, Iraq.
2Iraqi Medical Board Neurology, Ministry of Health, Baghdad Teaching Hospital, Baghdad, Iraq.
J Pure Appl Microbiol, 2019, 13 (1): 545-551 | Article Number: 5416
Received: 01/01/2019 | Accepted: 19/02/2019 | Published: 28/03/2019
Abstract

The current study was focused on patients with Multiple sclerosis between the ages group of 20 – 60. The objective of this study is to decide the level of 25-hydroxyvitamin D3 status in patients with multiple sclerosis (MS) and its engagement, with disease activity. A total of 31 cases have participated from Baghdad Teaching Hospital in Baghdad, Iraq during the period between March and April 2018. The results shows that, only significant finding was that, supplements for Vitamin D significantly increased its mean level in patients with Multiple Sclerosis (P < 0.05).

Keywords

Multiple sclerosis, Vitamin-D.

Article Metrics

Article View: 2733

Share This Article

© The Author(s) 2019. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.